This is the authors' abstract. We don't add key points for this paper.
Early detection of clinically significant prostate cancer (csPCa) has improved since the introduction of magnetic resonance imaging (MRI) and guided biopsies for this purpose; however, suspicion of PCa is still based on elevated serum prostate-specific antigen and/or abnormal digital rectal examination. At present, the decision to perform a prostate biopsy primarily depends on the Prostate Imaging-Reporting and Data System (PI-RADS) score for lesions observed on MRI. Prostate biopsy is typically avoided when negative MRI (PI-RADS <3) is reported owing to its high negative predictive value; nevertheless, uncertain scenarios remain...
Answers are grounded in this paper and cite their sources.
No takes yet. Share an insight, caveat, or question.
Moróte et al. (2022) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: